22/09/2014 20:20:35 Free Membership Login

Parexel News (NASDAQ:PRXL)

DateTimeSource
Headline
09/11/20146:00AMPRNUSPAREXEL Expands Industry-Leading Perceptive® Partner Program With Addition Of CRF Health And Clinical Ink
PAREXEL Expands Industry-Leading Perceptive® Partner Program With Addition Of CRF Health And Clinical Ink Life sciences service providers leverage PAREXEL's eClinical solutions to simplify drug development for customers through technology partnership initiative PR Newswire BOSTON, Sept. 11, 2014 BOSTON, Sept. 11, 2014... More...>>
09/04/20146:00AMPRNUSDr. Tracy Tsuetaki Joins Parexel As Senior Vice President Of Peri/Post-Approval Services And PAREXEL Consulting
Dr. Tracy Tsuetaki Joins Parexel As Senior Vice President Of Peri/Post-Approval Services And PAREXEL Consulting PR Newswire BOSTON, Sept. 4, 2014 BOSTON, Sept. 4, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the appointment... More...>>
08/20/201410:00AMPRNUSPAREXEL International To Present At Baird Healthcare Conference
PAREXEL International To Present At Baird Healthcare Conference PR Newswire BOSTON, Aug. 20, 2014 BOSTON, Aug. 20, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Baird Healthcare Conference in New York.  Ingo Bank, Senior Vice President and Chief... More...>>
08/06/20144:05PMPRNUSPAREXEL International Reports Fourth Quarter And Fiscal Year 2014 Results
PAREXEL International Reports Fourth Quarter And Fiscal Year 2014 Results PR Newswire BOSTON, Aug. 6, 2014 BOSTON, Aug. 6, 2014 /PRNewswire/ --            Fourth Quarter Fiscal Year 2014 Results (compared to Fourth Quarter Fiscal Year 2013) 10.2% growth in consolidated service revenue to $510.6 million GAAP... More...>>
07/10/20149:30AMPRNUSPAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2014 Earnings Release And Conference Call
PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2014 Earnings Release And Conference Call PR Newswire BOSTON, July 10, 2014 BOSTON, July 10, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Fourth Quarter and Fiscal Year 2014 on Wednesday... More...>>
07/01/20144:30PMPRNUSPAREXEL International Announces Acquisition Of ATLAS Medical Services, A Provider Of Clinical Research Services In Turkey
PAREXEL International Announces Acquisition Of ATLAS Medical Services, A Provider Of Clinical Research Services In Turkey PR Newswire BOSTON, July 1, 2014 BOSTON, July 1, 2014 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL)("PAREXEL" or the "Company"), a global clinical research organization, announced... More...>>
06/24/20144:05PMPRNUSPAREXEL International Issues Earnings Guidance In Conjunction With Investor Day
PAREXEL International Issues Earnings Guidance In Conjunction With Investor Day PR Newswire BOSTON, June 24, 2014 BOSTON, June 24, 2014 /PRNewswire/ -- In conjunction with its Investor Day being held tomorrow, PAREXEL International Corporation (Nasdaq: PRXL) has reconfirmed its forward-looking guidance for the fourth... More...>>
06/23/20146:00AMPRNUSPAREXEL Named 2014 Best Performing CRO In Taiwan For Drug Development And Healthcare Industry Leadership
PAREXEL Named 2014 Best Performing CRO In Taiwan For Drug Development And Healthcare Industry Leadership Company recognized by Foundation of Medical Professionals Alliance in Taiwan PR Newswire BOSTON and TAIPEI, Taiwan, June 23, 2014 BOSTON and TAIPEI, Taiwan, June 23, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ:... More...>>
06/19/20146:00AMPRNUSPAREXEL Wins 2014 IABC Gold Quill Merit Award For Internal Communications
PAREXEL Wins 2014 IABC Gold Quill Merit Award For Internal Communications International recognition for driving business performance through effective employee engagement PR Newswire BOSTON, June 19, 2014 BOSTON, June 19, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services... More...>>
06/17/20149:31AMPRNUSPAREXEL Invites Public To Listen To Live Webcast Of Its Investor Day June 25, 2014
PAREXEL Invites Public To Listen To Live Webcast Of Its Investor Day June 25, 2014 PR Newswire BOSTON, June 17, 2014 BOSTON, June 17, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it will provide a live webcast of its Investor... More...>>
06/16/201412:00PMPRNUSPAREXEL Cuts Clinical Trial Start-Up Time For Sponsors By Weeks With New Version Of Industry-Leading ClinPhone® RTSM Services
PAREXEL Cuts Clinical Trial Start-Up Time For Sponsors By Weeks With New Version Of Industry-Leading ClinPhone® RTSM Services Latest RTSM technology features standardized study components for faster implementation and greater design flexibility PR Newswire BOSTON, June 16, 2014 BOSTON, June 16, 2014 /PRNewswire/ -- PAREXEL... More...>>
06/16/20148:30AMPRNUSParexel International Announces $150 Million Accelerated Share Repurchase Program
Parexel International Announces $150 Million Accelerated Share Repurchase Program PR Newswire BOSTON, June 16, 2014 BOSTON, June 16, 2014 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL) announced today that it has entered into an Accelerated Share Repurchase (ASR) agreement with Goldman Sachs & Co... More...>>
06/11/201410:33AMPRNUSPAREXEL International to Present at Wells Fargo Healthcare Conference
PAREXEL International to Present at Wells Fargo Healthcare Conference PR Newswire BOSTON, June 11, 2014 BOSTON, June 11, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Wells Fargo Healthcare Conference in Boston.  James Winschel, Executive Vice... More...>>
06/04/201410:10AMPRNUSPAREXEL International To Present At Goldman Sachs Healthcare Conference
PAREXEL International To Present At Goldman Sachs Healthcare Conference PR Newswire BOSTON, June 4, 2014 BOSTON, June 4, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Goldman Sachs Healthcare Conference in Palos Verdes, CA.  James Winschel, Executive... More...>>
06/02/20144:05PMPRNUSPAREXEL International Announces Stock Repurchase Program
PAREXEL International Announces Stock Repurchase Program PR Newswire BOSTON, June 2, 2014 BOSTON, June 2, 2014 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL) announced today that its Board of Directors has approved a stock repurchase program authorizing the repurchase of up to $150 million of the Company's... More...>>
05/29/20142:17PMPRNUSJames F. Winschel Appointed to the Board of Directors of Cambrex Corporation
James F. Winschel Appointed to the Board of Directors of Cambrex Corporation PR Newswire EAST RUTHERFORD, N.J., May 29, 2014 EAST RUTHERFORD, N.J., May 29, 2014 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex")  announced today that James F. Winschel, Jr., age 64, was appointed to the Company's Board of Directors... More...>>
05/28/201410:00AMPRNUSPAREXEL International To Present At Jefferies Healthcare Conference
PAREXEL International To Present At Jefferies Healthcare Conference PR Newswire BOSTON, May 28, 2014 BOSTON, May 28, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Jefferies Healthcare Conference in New York, NY.  Josef von Rickenbach, Chairman... More...>>
05/27/20148:45AMPRNUSPAREXEL Names Dr. Sy Pretorius Chief Scientific Officer
PAREXEL Names Dr. Sy Pretorius Chief Scientific Officer To lead integration of Company's global scientific expertise and services to meet end-to-end customer drug development needs PR Newswire BOSTON, May 27, 2014 BOSTON, May 27, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical... More...>>
05/20/20146:00AMPRNUSPAREXEL Launches Perceptive MyTrials® Data-Driven Monitoring To Increase Patient Safety And Reduce Clinical Trial Costs
PAREXEL Launches Perceptive MyTrials® Data-Driven Monitoring To Increase Patient Safety And Reduce Clinical Trial Costs Technology solution designed to improve monitoring effectiveness and efficiency PR Newswire BOSTON, May 20, 2014 BOSTON, May 20, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading... More...>>
05/14/20142:00PMPRNUSPAREXEL International To Present At UBS Healthcare Conference
PAREXEL International To Present At UBS Healthcare Conference PR Newswire BOSTON, May 14, 2014 BOSTON, May 14, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the UBS Healthcare Conference in New York, NY. James Winschel, Executive Vice President, will... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq prxl140922 20:20